Dobak John's Form 4/A amendment
AmendedDermTech, Inc. (DMTK) · filed Apr 6, 2023
- Accession no.
- 0001209191-23-023658
- Filed
- Apr 6, 2023
- Trade date
- Mar 9-13, 2023
- Filing delay
- 28 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Mar 13, 2023
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $5.08K. It was filed 28 days after the trade.
This amendment replaces 0001209191-23-018303 (filed Mar 13, 2023).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dobak JohnCIK 0001787176 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 9, 2023 | Common Stock | AGrant or awardAcquired | +56,407 | $0.00 | $0 | 700,252 | Direct | |
| Mar 13, 2023 | Common Stock | SSaleDisposed | −1,559 | $3.26 | −$5,082.34 | 698,693 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.